Three dimensional human small intestine models for ADME-Tox studies.
In vitro human small intestine models play a crucial part in preclinical drug development. Although conventional 2D systems possess many advantages, such as facile accessibility and high-throughput capability, they can also provide misleading results due to their relatively poor recapitulation of in vivo physiology. Significant progress has recently been made in developing 3D human small intestine models, suggesting that more-reliable preclinical results could be obtained by recreating the 3D intestinal microenvironment in vitro. Although there are still many challenges, 3D human small intestine models have the potential to facilitate drug screening and drug development.
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Jiajie
J
Yu
Department of Chemical Engineering, Northeastern University, Boston, MA, USA.
Rebecca L
RL
Carrier
Department of Biological and Environmental Engineering, Cornell University, Ithaca, NY, USA.
John C
JC
March
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address: griff@mit.edu.
Linda G
LG
Griffith
D000818:Animals; D004353:Drug Evaluation, Preclinical; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007421:Intestine, Small / Q000378:metabolism*; D008954:Models, Biological; D010599:Pharmacokinetics